RNA-binding proteins represent a new class of drug targets for triple-negative breast

[News]

In cancer research, it's a common goal to find something about cancer cells -- some sort of molecule -- that drives their ability to survive, and determine if that molecule could be inhibited with a drug, halting tumor growth. Even better: The molecule isn't present in healthy cells, so they remain untouched by the new therapy.

More... (https://www.news-medical.net/news/20210702/RNA-binding-proteins-represent-a-new-class-of-drug-targets-for-triple-negative-breast-cancer.aspx)